Eric Brouwer

1.3k total citations
21 papers, 1.1k citations indexed

About

Eric Brouwer is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Eric Brouwer has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Eric Brouwer's work include Pharmacogenetics and Drug Metabolism (6 papers), Cancer Treatment and Pharmacology (6 papers) and Cancer therapeutics and mechanisms (6 papers). Eric Brouwer is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Cancer Treatment and Pharmacology (6 papers) and Cancer therapeutics and mechanisms (6 papers). Eric Brouwer collaborates with scholars based in Netherlands, Germany and United States. Eric Brouwer's co-authors include Alex Sparreboom, Jaap Verweij, Walter J. Loos, Peter de Bruijn, Kees Nooter, G. Stoter, Lia van Zuylen, Hans Gelderblom, Jaap Verweij and Theo M. Luider and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Analytical Biochemistry.

In The Last Decade

Eric Brouwer

20 papers receiving 1.0k citations

Peers

Countries citing papers authored by Eric Brouwer

Since Specialization

Citations

This map shows the geographic impact of Eric Brouwer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Brouwer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Brouwer more than expected).

Fields of papers citing papers by Eric Brouwer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Brouwer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Brouwer. The network helps show where Eric Brouwer may publish in the future.

Co-authorship network of co-authors of Eric Brouwer

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Brouwer. A scholar is included among the top collaborators of Eric Brouwer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Brouwer. Eric Brouwer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diagnostic accuracy of a fully automated multiplex celiac disease antibody panel for serum and plasma 2019 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Jeff Terryberry, (unknown), (unknown), (unknown), Eric Brouwer, Detlef Schuppan, Stefano Guandalini	3
2	Multiplex serology of paraneoplastic antineuronal antibodies 2013 ·Journal of Immunological Methods ·(unknown), Eric Brouwer, Esther Hulsenboom, Martijn M. VanDuijn, Marco W.J. Schreurs, Herbert Hooijkaas, Peter A.E. Sillevis Smitt	6
3	A microsimulation model of Dutch tourist behaviour an exploration of Dutch panel data 2013 ·Università degli Studi di Bologna ·(unknown), Eric Brouwer	0
4	Mass spectrometric detection of antigen-specific immunoglobulin peptides in paraneoplastic patient sera 2012 ·Journal of Autoimmunity ·(unknown), Martijn M. VanDuijn, Eric Brouwer, Lennard J. M. Dekker, (unknown), Theo M. Luider, Peter Sillevis Smitt	14
5	An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions 2010 ·Analytical and Bioanalytical Chemistry ·Lennard J. M. Dekker, (unknown), Eric Brouwer, Martijn M. VanDuijn, Peter A.E. Sillevis Smitt, Theo M. Luider	29
6	Comparison of carboxylated and Penta-His microspheres for semi-quantitative measurement of antibody responses to His-tagged proteins 2008 ·Journal of Immunological Methods ·Nelianne J. Verkaik, Eric Brouwer, Herbert Hooijkaas, Alex van Belkum, Willem J. B. van Wamel	50
7	Targeting malignant gliomas with a glial fibrillary acidic protein (GFAP)‐selective oncolytic adenovirus 2007 ·The Journal of Gene Medicine ·(unknown), Eric Brouwer, (unknown), (unknown), Marion de Jong, Rob C. Hoeben, B. de Leeuw, Peter Sillevis Smitt	19
8	Locoregional delivery of adenoviral vectors. 2006 ·PubMed ·(unknown), (unknown), Eric Brouwer, Rob C. Hoeben, Marion de Jong, (unknown), Peter A.E. Sillevis Smitt	7
9	Gene Expression Profiles Associated with Treatment Response in Oligodendrogliomas 2005 ·Cancer Research ·Pim J. French, Sigrid Swagemakers, Jord H.A. Nagel, Mathilde C.M. Kouwenhoven, Eric Brouwer, Peter J. van der Spek, Theo M. Luider, Johan M. Kros, Martin J. van den Bent, Peter A. Sillevis Smitt	99
10	Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles 2001 ·Cancer Chemotherapy and Pharmacology ·Lia van Zuylen, M. O. Karlsson, Jaap Verweij, Eric Brouwer, Peter de Bruijn, Kees Nooter, G. Stoter, Alex Sparreboom	109
11	Inter-relationships of paclitaxel disposition, infusion duration and Cremophor EL kinetics in cancer patients 2000 ·Anti-Cancer Drugs ·Lia van Zuylen, Luca Gianni, Jaap Verweij, K. Mross, Eric Brouwer, Walter J. Loos, Alex Sparreboom	52
12	Liposomal lurtotecan (NX211): determination of total drug levels in human plasma and urine by reversed-phase high-performance liquid chromatography 2000 ·Journal of Chromatography B Biomedical Sciences and Applications ·Walter J. Loos, Diederik F.S. Kehrer, Eric Brouwer, Jaap Verweij, Peter de Bruijn, Marta Hamilton, (unknown), Kees Nooter, G. Stoter, Alex Sparreboom	19
13	Gender-dependent pharmacokinetics of topotecan in adult patients 2000 ·Anti-Cancer Drugs ·Walter J. Loos, Hans Gelderblom, Jaap Verweij, Eric Brouwer, Maja J. De Jonge, Alex Sparreboom	25
14	Measurement of Fraction Unbound Paclitaxel in Human Plasma 2000 ·Drug Metabolism and Disposition ·Eric Brouwer, Jaap Verweij, Peter de Bruijn, Walter J. Loos, (unknown), (unknown), Alex Sparreboom	84
15	Phase I Pharmacologic Study of Oral Topotecan and Intravenous Cisplatin: Sequence-Dependent Hematologic Side Effects 2000 ·Journal of Clinical Oncology ·Maja J.A. de Jonge, Walter J. Loos, Hans Gelderblom, André Planting, Maria E.L. van der Burg, Alex Sparreboom, Eric Brouwer, V van Beurden, (unknown), E. Doyle, (unknown), Graham Ross, Jaap Verweij	56
16	Pharmacokinetic, Metabolic, and Pharmacodynamic Profiles in a Dose-Escalating Study of Irinotecan and Cisplatin 2000 ·Journal of Clinical Oncology ·Maja J.A. de Jonge, Jaap Verweij, Peter de Bruijn, Eric Brouwer, Ron H.J. Mathijssen, Robbert J. van Alphen, (unknown), Laurent Vernillet, Christian Jacques, Alex Sparreboom	51
17	Role of erythrocytes and serum proteins in the kinetic profile of total 9-amino-20(S)-camptothecin in humans 1999 ·Anti-Cancer Drugs ·Walter J. Loos, Jaap Verweij, Hans Gelderblom, Maja J. De Jonge, Eric Brouwer, B.K. Dallaire, Alex Sparreboom	32
18	Disposition of [G-3H]paclitaxel and Cremophor EL in a Patient with Severely Impaired Renal Function 1999 ·Drug Metabolism and Disposition ·Hans Gelderblom, Jaap Verweij, Eric Brouwer, (unknown), Peter de Bruijn, Kees Nooter, G. Stoter, Alex Sparreboom	20
19	Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications. 1999 ·PubMed ·Alex Sparreboom, Lia van Zuylen, Eric Brouwer, Walter J. Loos, Peter de Bruijn, Hans Gelderblom, (unknown), Kees Nooter, G. Stoter, Jaap Verweij	277
20	Linearized Colorimetric Assay for Cremophor EL: Application to Pharmacokinetics after 1-Hour Paclitaxel Infusions 1998 ·Analytical Biochemistry ·Eric Brouwer, Jaap Verweij, Bernhard Hauns, Walter J. Loos, Kees Nooter, K. Mross, G. Stoter, Alex Sparreboom	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact